麻豆传媒

Social isolation may lead to fewer resources for managing the condition

Prices went down but reductions in new oxygen prescriptions and discontinuations were minimal

Living in polluted zip codes was linked to worse outcomes after transplant

There remains an unmet need for effective COPD therapies, expert says

Phase III trial program showed 30% to 34% reduction in moderate or severe exacerbations

However, treatment group crossovers muddied the waters in open-label Chinese trial

"We should be cautious about using drugs off-label," investigator says

They'll "still have that ball and chain, but maybe we've lightened it a little bit," says expert

An immediate appointment to a smoking cessation clinic shows benefit versus usual care

Propellants in metered-dose inhalers are the biggest culprit

"No race is spared, although people of color fare worse," says project leader

Health news and commentary gathered by 麻豆传媒 staff

Nonphysician program linked to lower all- and specific-cause mortality risks

Gregory Downey, MD, explains how rising temperatures are driving respiratory health problems